Guaifenesin 400mg
Product Images NDC 10135-682

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Guaifenesin 400mg (NDC 10135-682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelndc 10135-0682-30guaifenesin400 mg30 Caplets (Guaifenesin 400mg 01)

Label for Guaifenesin 400 mg caplets by Marlex Pharmaceuticals Inc. The label states the active ingredient is guaifenesin at 400 mg strength, with 30 caplets per container. It includes Drug Facts information detailing uses, warnings, and safety instructions, along with the NDC 10135-0682-30 and a barcode.*

FDA Label Image

Principal Display Panelndc 10135-0682-30guaifenesin400 mg30 Caplets (Guaifenesin 400mg 02)

A continuation of the Drug Facts label for Guaifenesin 400mg by Marlex Pharmaceuticals Inc. This panel includes directions for use, temperature storage information, and active ingredient details. It advises not to exceed six doses in 24 hours, restricts use in children under 12 years, and lists inactive ingredients such as hydroxypropyl cellulose and citric acid.*

FDA Label Image

Principal Display Panelndc 10135-0682-60guaifenesin400 mg60 Caplets (Guaifenesin 400mg 03)

Label for Guaifenesin 400 mg caplets by Marlex Pharmaceuticals Inc. The label states the strength as 400 mg and the package contains 60 caplets. It includes drug facts with active ingredient information, usage instructions, warnings, manufacturer details, and a barcode with NDC 10135-0682-60.*

FDA Label Image

Principal Display Panelndc 10135-0682-60guaifenesin400 mg60 Caplets (Guaifenesin 400mg 04)

A Drug Facts panel continuation for Guaifenesin 400mg showing warnings for pregnant or breastfeeding women and overdose instructions. It provides directions for dosing by age group, storage conditions (15°-30°C or 59°-86°F), and lists the inactive ingredients including magnesium stearate, colloidal silicon dioxide, gelatin, sodium lauryl sulfate, and stearic acid.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.